Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.52 |
| ▸ | PNMT | P11086 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | MC4R | P32245 | 1/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10365169 | 1.00 | SIGMAR1 (0.52) | SIGMAR1PNMTMEN1KMT2ATSHR | |
| SCHEMBL4501237 | 1.00 | SIGMAR1 (0.52) | SIGMAR1PNMTMEN1KMT2ATSHR | |
| Hydrochloric Acid SCHEMBL9005477 | 0.98 | SIGMAR1 (0.50) | SIGMAR1PNMTMEN1KMT2ATSHR | |
| Hydrochloric Acid SCHEMBL9005481 | 0.98 | SIGMAR1 (0.50) | SIGMAR1PNMTMEN1KMT2ATSHR | |
| SCHEMBL7270268 | 0.89 | SIGMAR1 (0.61) | SIGMAR1MEN1KMT2ATSHRGAA | |
| SCHEMBL6990785 | 0.83 | SIGMAR1 (0.53) | SIGMAR1MEN1KMT2ATSHRGAA | |
| SCHEMBL6990786 | 0.83 | SIGMAR1 (0.53) | SIGMAR1MEN1KMT2ATSHRGAA | |
| Methoxymethane SCHEMBL10628191 | 0.83 | SIGMAR1 (0.53) | SIGMAR1MEN1KMT2ATSHRGAA | |
| SCHEMBL9230592 | 0.81 | SIGMAR1 (0.50) | SIGMAR1PNMTMEN1KMT2AGAA | |
| SCHEMBL9230590 | 0.81 | SIGMAR1 (0.50) | SIGMAR1PNMTMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-53028161-A | — | — | None | — | — | JP | disclosed |
| JP-53028163-A | — | — | None | — | — | JP | disclosed |
| JP-55022699-A | — | — | None | — | — | JP | disclosed |
| US-7582627-B2 | 3-Amino-7-[3-(1-aminoethyl)-4-fluoropyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione; quinolone antibiotics; bactericides; for antibiotic- resistant bacterial infections, ciprofloxacin- resistant ones; inhibiting wild-type and quinolone- resistant mutants of DNA gryase | WARNER-LAMBERT COMPANY (US) | 2009-09-01 | — | — | US | disclosed |
| EP-1255739-B1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | WARNER LAMBERT CO (US) | 2008-06-11 | — | — | EP | disclosed |
| US-20060287308-A1 | 3-Aminoquinazolin-2,4-dione antibacterial agents | ZOETIS WLC LLC | 2006-12-21 | — | — | US | disclosed |
| US-7094780-B1 | 3-aminoquinazolin-2,4-dione antibacterial agents | WARNER LAMBERT COMPANY LLC (US) | 2006-08-22 | — | — | US | disclosed |
| US-20060183762-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | ZOETIS WLC LLC | 2006-08-17 | — | — | US | disclosed |
| EP-1255739-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY (US) | 2002-11-13 | — | — | EP | disclosed |
| WO-2001053273-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY (US) | 2001-07-26 | — | — | WO | disclosed |
| US-5576320-A | 1-heteruarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them | SANOFI (FR) | 1996-11-19 | — | — | US | disclosed |
| US-5565474-A | 1-heteroarylazetidines and -pyrrolidines process for their preparation and pharmaceutical compositions containing them | SANOFI (FR) | 1996-10-15 | — | — | US | disclosed |
| US-5410057-A | 1-heteroarylazetidines and -pyrrolidines | SANOFI (FR) | 1995-04-25 | — | — | US | disclosed |
| EP-0591030-A2 | 1-Heteroaryl-azetidines and -pyrrolidines as 5-HT3 agonists | SANOFI (FR) | 1994-04-06 | — | — | EP | disclosed |
| EP-0310854-B1 | PROCESS FOR THE MANUFACTURE OF 3-AMINO-1-BENZYL-PYRROLIDINES | BAYER AG (DE) | 1992-05-20 | — | — | EP | disclosed |
| US-4910319-A | Process for preparing 3-amino-1-benzylpyrrolidines | BAYER AKTIENGESELLSCHAFT (DE) | 1990-03-20 | — | — | US | disclosed |
| EP-0310854-A1 | Process for the manufacture of 3-amino-1-benzyl-pyrrolidines | BAYER AG (DE) | 1989-04-12 | — | — | EP | disclosed |
| JP-S5522699-A | NOVEL 3-AMINO-1-BENZYLPYRROLIDINE DERIVATIVE | YAMANOUCHI PHARMACEUT CO LTD | 1980-02-18 | — | — | JP | disclosed |
| JP-S5328163-A | NOVEL 1-BENZYL-3-PYRROLIDONEOXIME DERIVATIVES AND THEIR PREPARATION | YAMANOUCHI PHARMACEUT CO LTD | 1978-03-16 | — | — | JP | disclosed |
| JP-S5328161-A | PREPARATION OF 3-AMINO-1-BENZYLPYRROLIDINE DERIVATIVES | YAMANOUCHI PHARMACEUT CO LTD | 1978-03-16 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060183762-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | ABL1, NQO2, CBR3 | SIGMAR1 274/4885PNMT 4530/4885MEN1 3683/4885 |
| US-20060287308-A1 | 3-Aminoquinazolin-2,4-dione antibacterial agents | ABL1, NQO2, AAAS | SIGMAR1 272/4885PNMT 4537/4885MEN1 3666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.